2013年12月22日星期日

FDA Says Germ-Killing Soap Recommended For CKD Patients Could Actually Pose Severe Health Risks


The U.S. Food and Drug Administration (FDA) reported Monday December 16th, 2013 that there is NO EVIDENCE that antibacterial chemicals used in liquid soaps and washes help prevent the spread of germs, and there is some evidence they may even pose health risks. Chronic Kidney Disease (CKD) patients are told that they, " should stop using bar soap and use the antibacterial soap in a pump for showers and hand washing." They were also told that there were too many germs left on the bar soap and dialysis centers provide antibacterial soap for its patients.

Recommended Reading: Chronic Kidney Disease Patients Should Be Aware Of Bacteria And "Filth" In Commonly Used Spices

Further, some data suggest that long-term exposure to certain active ingredients used in antibacterial products, for example, triclosan (liquid soaps) and triclocarban (bar soaps) could post health risks, such as bacterial resistance or hormonal effects.

Recommended Reading: C. diff is a Life Threatening Bacteria for those with ESRD

Due to CKD patients' extensive exposure to the ingredients in antibacterial soaps, KidneyBuzz.com believes that there should be a clearly demonstrated benefit from using antibacterial soap to balance any potential risk. Also, readers should note that hand sanitizers, wipes and antibacterial products used in health care settings are not affected.

没有评论:

发表评论